A retrospective, population-based study has found that some of the oral contraceptives are tied to a lower risk for type 2 diabetes and prediabetes among women with polycystic ovary syndrome (PCOS).

An analysis of 64,051 women with PCOS revealed that they had around two-times greater risk for developing type 2 diabetes (adjusted HR 2.04) and dysglycemia (aHR 1.87) compared to the general population, reported researchers online in Diabetes Care. However, combined oral contraceptive pills (COCPs) were found to counter this risk over a median follow-up of 3.5 years. Women who were prescribed COCPs had a 16% to 17% reduced risk for type 2 diabetes. The risk reduction appeared to be similar for contraceptives with an antiandrogenic progestin component (aHR 0.84) and without it (aHR 0.83)… (Medpage Today)